Treating Metastatic NSCLC: Choosing the Best Treatment for Optimal Outcomes : Episode 8

Educating Patients About AEs Associated With KRAS-Targeted Therapies in NSCLC

February 12, 2025

Opinion

Video

Medical experts discuss approaches to patient education on managing potential adverse events associated with adagrasib and other KRAS-targeted therapies.

EP: 1.Sarah’s Journey With ALK+ Metastatic NSCLC

EP: 2.Patient Education: Preparing Patients for ALK Inhibitor Treatment

EP: 3.Strategies for Managing Neurotoxic AEs With Lorlatinib

EP: 4.Lorlatinib AE Management: Weight Gain and GI Issues

EP: 5.Multidisciplinary Approach to AE Management With Lorlatinib

EP: 6.Real-World Management of AEs with ALK Inhibitors

EP: 7.Eleanor’s Journey With KRAS+ Metastatic NSCLC

Now Viewing

EP: 8.Educating Patients About AEs Associated With KRAS-Targeted Therapies in NSCLC

EP: 9.Managing AEs Associated With Adagrasib for NSCLC

EP: 10.Goals of Care: in mNSCLC Balancing QOL and Treatment Maintenance

Video content above is prompted by the following:

How do you approach patient education regarding potential adverse events associated with adagrasib or other KRAS targeted therapies?

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!